Morin-Heights, QC – Capital Pro-Égaux Inc. announces that its wholly owned subsidiary, Technique d’usinage Sinlab Inc. (“Sinlab”), has entered into a Patent Licence Agreement with MIS Implants Technologies, Ltd. (“MIS Implants”). As part of the agreement, Sinlab granted MIS Implants an irrevocable, non-exclusive and non-transferable worldwide licence in and to all of its patents, including patents relating to its Technobar and Technoguide technologies, under terms undisclosed for confidentiality reasons.
Unlicenced entities should obtain an appropriate licence from Sinlab by contacting M. Jean Kingsley.
The Company previously announced settlement and/or licence agreements that include Biomet 3i, LLC (formerly Implant Innovations, Inc.); Delcam USA, Inc. and Delcam Holdings, Inc.; Cagenix, Inc.; Dentsply International Inc.; Nobel Biocare AB; Nobel Biocare Italiana S.r.l.; Nobel Biocare Holding AG; Nobel Biocare Deutschland GmbH; Nobel Biocare Canada, Inc.; Biocad Médical Inc.; Nobel Biocare USA, LLC; Nobel Biocare Procera, LLC; 3Shape A/S and exocad America, Inc.
Pro-Égaux through its wholly owned subsidiary, Technique d’usinage Sinlab Inc., is a company based in Lachenaie, Quebec, specialising mainly in the conception and design of titanium products to be used in the dental prosthesis restoration industry. – Capital Pro-Egaux Inc.